Previous 10 | Next 10 |
home / stock / cqpty / cqpty news
REHOVOT, Israel , Oct. 22, 2019 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative medicine company, today announced the Company's Chief Executive Officer Yehiel Tal was recently appointed as a member of the Industry Relations Committee of ISBF (International Society for Bi...
REHOVOT, Israel , Oct. 16, 2019 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative medicine company, today announced the Company's Chief Executive Officer Yehiel Tal will present at the Dawson James 5 th Annual Small Cap Growth Conference on Tuesday, October 29, 2019 a...
REHOVOT, Israel , Sept. 26, 2019 /PRNewswire/ -- CollPlant (NASDAQ: CLGN) , a regenerative medicine company, today announced financial results for the second quarter ended June 30, 2019 and provided an update on the Company's business developments. Certain metrics, including those ex...
REHOVOT, Israel , Sept. 9, 2019 /PRNewswire/ -- CollPlant (NASDAQ:CLGN) (the "Company"), a regenerative medicine company, announced it has closed on a total of $5.5 million in convertible loans. A group of U.S. accredited investors with deep experience in the 3D printing indust...
REHOVOT, Israel , Sept. 5, 2019 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative medicine company, today announced that Yehiel Tal, Chief Executive Officer will be presenting at the 21st Annual Global Rodman and Renshaw Investment Conference, sponsored by H. C. W...
REHOVOT, Israel , Sept. 3, 2019 /PRNewswire/ -- CollPlant (NASDAQ: CLGN) (the "Company"), a regenerative medicine company, announced it has entered into definitive agreements for up to $6.5 million funding in convertible loans. The capital raise is by way of a non-brokered privat...
REHOVOT, Israel , Aug. 5, 2019 /PRNewswire/ -- CollPlant (NASDAQ: CLGN) (the "Company"), a regenerative medicine company, announced today that it is developing 3D bioprinted implants for regeneration of breast tissue and has successfully produced first prototypes. The implants will...
REHOVOT, Israel , June 20, 2019 /PRNewswire/ -- CollPlant (NASDAQ: CLGN) (the "Company"), a regenerative medicine company, announced today that its corporate name has changed from "CollPlant Holdings Ltd." to "CollPlant Biotechnologies Ltd." effective on the opening of tradi...
REHOVOT, Israel , June 4, 2019 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative medicine company, today announced that the results from a clinical study conducted with its VergenixFG advanced wound care product will be presented at the 29th Conference of the European Woun...
REHOVOT, Israel , May 30, 2019 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative medicine company, today announced financial results for the first quarter ended March 31, 2019 and provided an update on the Company's business developments. Certain metrics, including those e...
News, Short Squeeze, Breakout and More Instantly...
Termination of Licensing Agreement for Bioprinting of Scaffolds for Lung Transplants PR Newswire REHOVOT, Israel , Feb. 25, 2021 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN) a regenerative and aesthetics medicine company, today announced that on ...